Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

TRxADE HEALTH, Inc. MEDS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score
53/100
1/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

TRxADE HEALTH, Inc. (MEDS) — Analyst outlook / Analyst consensus target is. Based on 2 analyst ratings, the consensus is bullish — 2 Buy.

MEDS Analyst Ratings

Buy
2
Ratings
2 Buy
Based on 2 analysts giving stock ratings to TRxADE HEALTH, Inc. in the past 3 months
Rating breakdown
Buy
2 100%
100%
Buy
2 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

People Also View

LFLY
LFLY
Leafly Holdings, Inc.
$37.00
+0.00%
 NVACF
NVACF
Nova Cannabis Inc.
$1.26
-2.77%
 SSY
SSY
SunLink Health Systems, Inc.
$1.12
+16.15%
 HEWA
HEWA
HealthWarehouse.com, Inc.
$0.09
+0.00%
 GABLF
GABLF
GABY Inc.
$0.00
+45.00%
 LFLYW
LFLYW
Leafly Holdings, Inc.
$0.00
-57.89%
 ALST
ALST
Allstar Health Brands, Inc.
$0.00
+0.00%
 BIMI
BIMI
BIMI International Medical Inc.
$0.00
+0.00%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message